FDA Approves First Freeze-Dried Plasma Product in the U.S.
The U.S. Food and Drug Administration has licensed the first freeze-dried plasma product in the U.S., representing a key development in blood-product availability and emergency medical care. This innovative product is expected to positively impact trauma care by offering a stable and readily accessible plasma source for critical patients.
- Published date: 18-08-2026 10:03 AM
On July 29, 2026, the U.S. Food and Drug Administration announced the licensing of the first-ever freeze-dried plasma product for use in the United States.
This regulatory approval marks a significant advancement in the availability of blood products, particularly benefiting emergency and trauma care settings.
The introduction of this freeze-dried plasma product aims to improve the management of critical bleeding by providing a more accessible and stable plasma option.
Healthcare providers and emergency responders may soon have enhanced capabilities for rapid plasma administration in urgent situations.